Crossmark

Methotrexate BAFFles anti-drug antibodies

Crossref DOI link: https://doi.org/10.1038/s41584-018-0064-y

Published Online: 2018-08-03

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cronstein, Bruce N.
License Information

Text and Data Mining valid from 2018-08-03
More Information

Article History

First Online: 3 August 2018

Competing interests

: B.C. received a grant from AstraZeneca to carry out an open label trial of ticagrelor in addition to methotrexate in patients with rheumatoid arthritis who have an inadequate response to methotrexate therapy.